Jennifer K. Kern Sliwa, PharmD

Neuroscience Medical Information, Janssen Scientific Affairs, LLC, Titusville, New Jersey

JCP
Esketamine Nasal Spray and Adverse Events Over Time
Original Research

September 19, 2022

This study looked at the occurrence and severity of adverse events over time with esketamine nasal spray in MDD patients also receiving an oral antidepressant.
David J. Williamson, Jagadish P. Gogate, Jennifer K. Kern Sliwa, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe